Invention Grant
- Patent Title: Biomarkers for predicting relapse in multiple sclerosis
-
Application No.: US14978772Application Date: 2015-12-22
-
Publication No.: US10280465B2Publication Date: 2019-05-07
- Inventor: Horea G. Rus , Cosmin A. Tegla
- Applicant: The United States of America as represented by the Department of Veteran Affairs, Department of Veterans Affairs , University of Maryland, Baltimore
- Applicant Address: US MD Baltmore US DC Washington
- Assignee: UNIVERSITY OF MARYLAND, BALTIMORE,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Current Assignee: UNIVERSITY OF MARYLAND, BALTIMORE,THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Current Assignee Address: US MD Baltmore US DC Washington
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883 ; G01N33/68
Abstract:
Methods of determining relapse in subjects having relapsing-remitting multiple sclerosis (RRMS) and predicting their response to glatiramer acetate (GA) using the biomarkers SIRT1, RGC-32, FasL and IL-21 are presented.
Public/Granted literature
- US20160194714A1 BIOMARKERS FOR PREDICTING RELAPSE IN MULTIPLE SCLEROSIS Public/Granted day:2016-07-07
Information query
